Skip to main content Back to Top
Advertisement

12/1/2021

Levetiracetam Injection

Products Affected - Description

    • Levetiracetam injection, Athenex, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 70860-0603-82
    • Levetiracetam injection, Athenex, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 70860-0602-82
    • Levetiracetam injection, Dr. Reddy's, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 43598-0636-10
    • Levetiracetam injection, Dr. Reddy's, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 43598-0637-10
    • Levetiracetam injection, Dr. Reddy's, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 43598-0635-10
    • Levetiracetam injection, Fresenius Kabi, 100 mg/mL, 5 mL vial, 10 count, NDC 63323-0400-05
    • Levetiracetam injection, Hikma, 100 mg/mL, 5 mL vial, 25 count, NDC 00143-9673-25
    • Levetiracetam injection, Pfizer, 100 mg/mL, 5 mL vial, 25 count, NDC 00409-1886-02

Reason for the Shortage

    • Athenex did not provide a reason for the shortage.
    • AuroMedics has levetiracetam injection available.
    • Dr. Reddy's did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma has levetiracetam injection available.
    • Mylan has levetiracetam injection available.
    • Pfizer has levetiracetam injection on shortage due to manufacturing delays.
    • Sagent did not provide a reason for the shortage.
    • Sun Pharma are not manufacturing levetiracetam injection at this time.
    • UCB has product available.
    • X-Gen has levetiracetam injection available.

Available Products

    • Keppra injection, UCB, 100 mg/mL, 5 mL vial, 10 count, NDC 50474-0002-63
    • Levetiracetam injection, Athenex, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 70860-0604-82
    • Levetiracetam injection, AuroMedics, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 55150-0247-47
    • Levetiracetam injection, AuroMedics, 100 mg/mL, 5 mL vial, 10 count, NDC 55150-0177-05
    • Levetiracetam injection, AuroMedics, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 55150-0248-47
    • Levetiracetam injection, AuroMedics, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 55150-0246-47
    • Levetiracetam injection, Mylan, 10 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0265-10
    • Levetiracetam injection, Mylan, 15 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0266-10
    • Levetiracetam injection, Mylan, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0255-10
    • Levetiracetam injection, Sagent, 100 mg/mL, 5 mL vial, 10 count, NDC 25021-0780-05
    • Levetiracetam injection, X-Gen, 100 mg/mL, 5 mL vial, 10 count, NDC 39822-4000-01

Estimated Resupply Dates

    • Athenex has levetiracetam 5 mg/mL 100 mL premixed bags and 10 mg/mL 100 mL premixed bags on back order and the company estimates a release date of mid-December 2021.
    • Dr. Reddy's has levetiracetam 5 mg/mL 100 mL premixed bags and 15 mg/mL 100 mL premixed bags available in limited supply. The 10 mg/mL 100 mL premixed bags are on back order and the company estimates a release date of early-December 2021.
    • Hikma has levetiracetam 100 mg/mL 5 mL vials on back order and the company estimates a release date of late-December 2021.
    • Pfizer has levetiracetam 100 mg/mL 5 mL vials on back order and the company estimates a release date of December 2021.
    • Sagent has levetiracetam 100 mg/mL 5 mL vials on back order and the company estimates a release date of February 2022.

Updated

Updated December 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 14, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.